The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Formulations of Curcumin Nanoparticles for Brain Diseases
Open accessAbstract
Curcumin is a polyphenol that is obtained from Curcuma longa and used in various areas, such as food and textiles. Curcumin has important anti-inflammatory and antioxidant properties that allow it to be applied as treatment for several emerging pathologies. Remarkably, there are an elevated number of publications deriving from the terms “curcumin” and “curcumin brain diseases”, which highlights the increasing impact of this polyphenol and the high number of study groups investigating their therapeutic actions. However, its lack of solubility in aqueous media, as well as its poor bioavailability in biological systems, represent limiting factors for its successful application. In this review article, the analysis of its chemical composition and the pivotal mechanisms for brain applications are addressed in a global manner. Furthermore, we emphasize the use of nanoparticles with curcumin and the benefits that have been reached as an example of the extensive advances in this area of health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mainly due to a sophisticated surface modification of the nanoparticle that allows adequate transit to the brain [215,216].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [216]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“, Doxil (Janssen, Titusville, FL, USA) for the treatment of certain types of cancer [83].”
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · cited 1×
“A more detailed report on the inhibition of Aβ aggregation revealed that, besides curcumin inhibiting fibril formation in vitro, it also inhibited the formation of Aβ oligomers and their toxicity in vivo [37].”
BackgroundTau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · cited 1×
“Its main clinical features are memory loss, behavioral changes, and cognitive impairment [126,127].”
BackgroundAggarwal, B. B., & Harikumar, K. B. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 2,139 · cited 1×
“It has been shown that curcumin possess anti-inflammatory and antioxidant properties [1,2].”
BackgroundCURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · Springer eBooks · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,740 · cited 1×
“It has been shown to decompose when it is exposed to UV/visible light, both in solution and in the solid state [26].”
BackgroundStability of curcumin in buffer solutions and characterization of its degradation products
Wang, Y., Pan, M., Cheng, A., Lin, L., Ho, Y., Hsieh, C., & Lin, J. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,709 · cited 2×
“2–6) than in alkaline pH (Figure 3); the degradation products found under hydrolytic conditions are: trans-6-(4′-hydroxy-3′-methoxyphenyl)-2,4-dioxo-5-hexenal, ferulic acid, ferulic aldehyde, feruloylmethane, and vanillin [22,23].”
BackgroundNeuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640 · cited 1×
“Interleukins such as IL-1β, IL-6, and IL-23, and cytokines such as TNF, interferon gamma (IFNγ), and granulocyte/macrophage colony-stimulating factor (GM-CSF), chemokines (such as CCL2, CCL5, and CXCL1), secondary messengers (nitric oxide and prostaglandins), and ROS are also mediators for the neuroinflammatory respon…”
BackgroundThe Chemistry of Curcumin: From Extraction to Therapeutic Agent
Priyadarsini, K. I. (2014) · Molecules · doi:10.3390/molecules191220091 · Cited by 1,520 · cited 9×
“From a structural point of view, there are three chemical entities in the molecule: two aromatic ring systems containing o-methoxy phenolic groups linked by a seven-carbon spacer consisting of an α,β-unsaturated β-diketone moiety [11].”
BackgroundMethodResultInfluentialActivation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,399 · cited 1×
“These authors reported that curcumin reduced the transcription and secretion of TNF-α, and also IL-6, which is induced by palmitate, and induces the nuclear translocation of NF-κB in a concentration-dependent manner [48,49].”
Phase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,260 · cited 1×
“1 nmol/L after one hour of dosing on days one, two, eight, and 29 of the administration [65].”
Background
Flagged first, then by citations
Research works printed but not linked: 3
- Alsamydai, 2018, Pharmacological aspects of curcumin: Review article, Int. J. Pharmacogn., 5, 313
- Andrew, W. (2017). Nanostructures for curcumin delivery: Posibilities and challenges. Nano and -Micro Drug Delivery Systems, Elsevier Science Ltd Desing and Fabrication.
- Sharma, 2012, Development and validation of UV spectrophotometric method for the estimation of curcumin in bulk drug and pharmaceutical dosage forms, Int. J. Drug Dev. Res., 4, 375
Cited by
Sorted by citations
Items 101–190 of 190
Ramasubramanian, B., Reddy, V. S., Chellappan, V., & Ramakrishna, S. (2022) · Biosensors · doi:10.3390/bios12121176 · Cited by 13
Wojtyłko, M., Kunstman, P., Bartylak, H., Raszewski, Ł., Osmałek, T. Z., & Froelich, A. (2023) · Applied Sciences · doi:10.3390/app13137809 · Cited by 11
Potential Ayurvedic Herbs for Neurodegenerative Diseases: A review
Sahu, D., Bhushan, S., Das, D., Debnath, S. K., Barik, L., Meena, V., Singh, V., Dixit, A. K., & Prasad, P. (2021) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2021.00015 · Cited by 11
Liu, S., Zhou, S., Wang, B., & Jia, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112964 · Cited by 10
Review on encapsulating bioactive compounds in spices
Babu, A., Shams, R., Dash, K. K., Bashir, O., Mukarram, S. A., & Kovács, B. (2025) · Food and Humanity · doi:10.1016/j.foohum.2025.100583 · Cited by 10
Chen, X., Yan, Z., Cheng, W., Zhang, D., Zhang, R., Duan, H., Zhang, L., Ma, X., Hu, J., Kang, J., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321752 · Cited by 15
Sharma, D. K. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2561788 · Cited by 11
“…endocytosis mechanism makes it easier for the lipophilic particles in Ne to pass the BBB. curcuma longa has a naturally occurring polyphenol component called curcumin. it can lessen inflammation brought on by protein aggregation in neuronal cells and amyloid beta protein aggregation [92].”
Cortés, H., Reyes‐Hernández, O. D., González‐Torres, M., Vizcaíno‐Dorado, P. A., Prado-Audelo, M. L. D., Alcalá-Alcalá, S., Sharifi‐Rad, J., Figueroa‐González, G., Carmen, M. G., Florán, B., et al. (2021) · Cellular and Molecular Biology · doi:10.14715/cmb/2021.67.1.15 · Cited by 10
Self-citationZhao, Y., Hu, W., Zhang, S., Liao, Y., Zha, K., Yu, C., Zhang, Z., Zhang, W., Mi, B., Cao, F., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202506623 · Cited by 9
Yaman, Y. T., Vural, O. A., Bolat, G., & Abacı, S. (2023) · Microchemical Journal · doi:10.1016/j.microc.2023.108773 · Cited by 9
Yıldız, G., Aydoğmuş, Z., Şenkal, B. F., & Turan, G. T. (2019) · Food Analytical Methods · doi:10.1007/s12161-019-01555-y · Cited by 9
Bissacotti, B. F., Copetti, P. M., Bottari, N. B., Gündel, S. D. S., Machado, A. K., Sagrillo, M. R., Ourique, A. F., Morsch, V. M., & Silva, A. S. D. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.2015242 · Cited by 8
“Nevertheless, because of the disadvantages of the substance in free form, nanoformulations at the same concentrations or even lower than those mentioned may deliver more satisfactory results by controlling the release of curcumin and increasing its bioavailability, in addition to crossing the blood-brain barrier and r…”
BackgroundInfluentialBhuyan, N., Ghose, S., Biswas, N., Sultan, J. A., & Laloo, D. (2024) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-024-00271-0 · Cited by 7
“Numerous studies have reported on the use of nanoparticles with natural products and their compounds, such as epigal-locatechin-3-gallate for treating AD [32], rosmarinic acid in managing HD [33], and curcumin for brain diseases [34].”
Egba, S. I., Edeh, M. O., Uchenna, O. N., Igwe, M. C., & Ogbodo, J. O. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s564106 · Cited by 11
Yakubu, J. Y., Tagit, O., & Pandey, A. V. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2619094 · Cited by 7
Polat, D. Ç., Karadağ, A. E., Köprülü, R. E. P., Karantas, I. D., Mutlu, G., Çağlar, E. Ş., Okur, M. E., Okur, N. Ü., & Siafaka, P. I. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220411104128 · Cited by 7
Paknia, F., Parchami, N., Nasry, N., & Mohabatkar, H. (2022) · Journal of Shahrekord University of Medical Sciences · doi:10.34172/jsums.2022.24 · Cited by 7
Temporal Profile of Reactive Astrocytes after Ischemic Stroke in Rats
Stadler, J., Schurr, H., Doyle, D., Garmo, L. G., Srinageshwar, B., Spencer, M. R., Petersen, R. B., Dunbar, G. L., & Rossignol, J. (2022) · Neuroglia · doi:10.3390/neuroglia3030007 · Cited by 7
“The cycle of oxidative stress and neuroinflammation further increases the activation of deleterious signaling pathways implicated in the production of numerous pro-inflammatory cytokines that contribute to neuronal damage [13,14].”
BackgroundImmunoregulatory effects of nanocurcumin in inflammatory milieu: Focus on COVID-19
Arab, F. L., Hoseinzadeh, A., Mohammadi, F. S., Rajabian, A., Faridzadeh, A., & Mahmoudi, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116131 · Cited by 8
Torres, C. A., Mendes, N. V., Baldin, S. L., Bernardo, H. T., Vieira, K. M., Scussel, R., Silveira, G. D. B., Silveira, P. C. L., Machado‐de‐Ávila, R. A., & Rico, E. P. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.01.011 · Cited by 7
Juncker, R. B., Lazazzera, B. A., & Billi, F. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15075 · Cited by 7
Hassan, R. A., Al-Amrani, W. A., Alwany, A. B., & Obaid, J. M. A. S. (2026) · Discover Nano · doi:10.1186/s11671-026-04665-9 · Cited by 10
Lin, Y., Liang, Y., Zhang, C., Liu, L., & Lin, F. (2024) · Antioxidants · doi:10.3390/antiox13070826 · Cited by 6
“Curcumin, a chemical derived from turmeric, has solid antioxidant and anti-inflammatory properties [19]; the ROS-scavenging properties of curcumin are owed to its hydroxy phenolic groups.”
Review: The Chemistry, Toxicity and Antibacterial Activity of Curcumin and Its Analogues
Denison, H. J., Schwikkard, S., Khoder, M., & Kelly, A. F. (2023) · Planta Medica · doi:10.1055/a-2157-8913 · Cited by 6
Evaluating the effect of curcumin on the metacestode of Taenia crassiceps
Martínez-González, J. D. J., Ríos-Morales, S. L., Guevara‐Flores, A., Ramos‐Godínez, M. D. P., Saavedra, A. L., Rendón, J. L., & Mena, I. P. D. A. (2022) · Experimental Parasitology · doi:10.1016/j.exppara.2022.108319 · Cited by 6
Pediaditakis, I., Tsakali, S., Lemieux, M. R., Brennan, M., Robinson, W. H., Papapetropoulos, S., & Papapetropoulos, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100118 · Cited by 8
Chowdhury, S., Kumari, G., & Jit, T. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100249 · Cited by 5
Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
Paccione, N., Rahmani, M., Barcia, E., & Negro, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010013 · Cited by 5
Biopolymer-Based Hydrogel Wound Dressing
Alibolandi, M., Bagheri, E., Mohammadi, M., Sameiyan, E., & Ramezani, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821185-4.00019-1 · Cited by 5
Lipid nanocarriers encapsulating herbal drugs for brain diseases therapy
Gad, S., El-Gogary, R. I., Geneidi, A. S., & Hathout, R. M. (2023) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2023.202432.1115 · Cited by 5
“Such properties include particle size, surface charge, and functionality [61, 63].”
BackgroundGuo, Y., Long, C., Ni, J., Zeng, J., Wang, J., Dai, Y., & Zhao, J. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.138929 · Cited by 4
Iurascu, T., Iacob, A.-T., Urîtu, C. M., Marangoci, N. L., Coroabǎ, A., Trofin, A. M., Profire, B.-Ș., Baican, M. C., Sava, A., Pinteala, T., et al. (2026) · Polymers · doi:10.3390/polym18050574 · Cited by 4
Iurciuc, C. E., Vochița, G., Gherghel, D., Mihai, C. T., Vasiliu, S., Racoviță, Ș., Cadinoiu, A. N., Logigan, C.-L., Hamcerencu, M., Mitu, F., et al. (2025) · Gels · doi:10.3390/gels11090708 · Cited by 4
Nano-curcumin in Neurodegenerative Diseases
Napagoda, M. T. (2023) · Springer eBooks · doi:10.1007/978-981-99-7731-4_15 · Cited by 4
Bwalya, F., Erdem, M., & Kaynak, M. S. (2025) · Nano Select · doi:10.1002/nano.202400162 · Cited by 4
Adjuvant Value of Turmeric Extract (Containing Curcumin) in Colorectal Cancer Management
Lau, C. B., & Yue, G. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-39855-2_7 · Cited by 4
İlhan, M., & ÖZTÜRK, M. (2024) · doi:10.2174/9789815305005124010008 · Cited by 3
Lachowicz, M., Kołodziejczyk, M. K., & Stańczak, A. (2021) · Farmacja Polska · doi:10.32383/farmpol/132183 · Cited by 3
“Zastosowanie nanocząsteczek umożliwia również wykazanie korzyści na poziomie mózgu, co może mieć potencjalne znaczenie w medycynie w przypadku takich schorzeń jak choroba Parkinsona lub Alzheimera [44].”
In Vitro Nanotoxicity: Toward the Development of Safe and Effective Treatments
Bueno, J. (2020) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-43855-5_4 · Cited by 4
da Silva, A. W. R., & Biegelmeyer, R. (2020) · Revista Fitos · doi:10.32712/2446-4775.2020.909 · Cited by 3
Design of Whey-Protein Stabilized Curcumin Nanoemulsions for Metabolic Syndrome Management
Jiménez-Escobar, M. P., Bautista-Hernández, S., Meza, S. H., Jiménez‐Fernández, M., Rascón-Díaz, M. P., Flores‐Andrade, E., Sánchez-Medina, A., & Pascual-Pineda, L. A. (2025) · BioNanoScience · doi:10.1007/s12668-025-01927-1 · Cited by 2
“These results were similar to those previously reported, where the melting temperature was 174 °C with an enthalpy of fusion of 71.06 J/mol [38, 39].”
InfluentialMohamed, R. A., Abdelaziz, R. H., Mohamed, M. S., Ahmed, N. H., & Ahmed, R. M. (2025) · Next research. · doi:10.1016/j.nexres.2025.100979 · Cited by 7
Rodríguez‐Esparragón, F., Cazorla-Rivero, S., Torrealba, E., Cánovas-Molina, Á., Hernández, A. N. G., Martín-Alfaro, R., Afonso-Medina, M. P., de Saavedra-Álvarez, M. T. M., Pérez-Santana, C. G., Bartolomé, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210866 · Cited by 3
“MtDNA-CN was determined as described [32].”
Functional Polymeric Membranes with Antioxidant Properties for the Colorimetric Detection of Amines
Kossyvaki, D., Bustreo, M., Contardi, M., Athanassiou, A., & Fragouli, D. (2023) · Sensors · doi:10.3390/s23229288 · Cited by 2
“…radical scavenging activity has been previously studied using the DPPH • assay, usually used for hydrophobic compounds, and ABTS • which has been used for both hydrophilic and lipophilic systems [27,31,67]. becomes a radical cation, which could react with another antioxidant molecule [65,66].”
BackgroundMethodFunctional foods and neuroinflammation: Focus on autism spectrum disorder and schizophrenia
Matrisciano, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91747-6.00012-3 · Cited by 2
Pornpitchanarong, C., Myat, Y. Y., Sahatsapan, N., Pengnam, S., Rojanarata, T., Opanasopit, P., Ngawhirunpat, T., & Patrojanasophon, P. (2024) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2024.100563 · Cited by 2
Nanotechnology: A Promising Approach in Nerve Regeneration
Chaskar, A. C., Azmi, N., Tiwari, A., & Kaur, N. (2022) · Current Nanoscience · doi:10.2174/1573413718666220509125522 · Cited by 2
Zuo, Q., Meng, H.-Q., Ommati, M. M., Yang, G.-D., Zhao, W., Zhao, J., Zhou, B.-H., & Wang, H.-W. (2025) · Poultry Science · doi:10.1016/j.psj.2025.104891 · Cited by 1
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273370166250610152453 · Cited by 1
Trujillo-Casarreal, J. D., Chávez, J. A. C., & Rodríguez‐González, V. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149019 · Cited by 1
Targeted Nanodelivery of WGX50 and Curcumin via Gold Nanoparticles for Alzheimer's Therapy
Lodhi, M. S., Maisam, M., Khan, M. T., Bibi, A., Wei, D., & Mou, K. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71045 · Cited by 2
“AuNP provide excellent drug loading and colloidal stability; cysteine capping allows stable insulin conjugation, enabling receptor-mediated transcytosis across the BBB compared with non-targeted formulations [29–31].”
Zhang, J., Nie, L., Ma, J., & Wang, X. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s548892 · Cited by 3
Nanodiagnostics: Advances and Implications in Clinical Diagnosis
Khanal, S., Sharma, A., Verma, R., & Kumar, D. (2026) · Springer eBooks · doi:10.1007/978-981-95-6714-0_7 · Cited by 1
Chahardehi, A. M., Abedian, O., Akbari, B., Rezaee, A., Nozari, S., Khoshkholgh, A., Nasiri, R., & Rahimi, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11592-6 · Cited by 1
Khotimah, H., Aulanni’am, A., Kurniawan, S. N., Puspita, O. E., Adianingsih, O. R., Mardhiyah, M., & Setiawan, A. (2022) · F1000Research · doi:10.12688/f1000research.118951.1 · Cited by 1
Brain specific delivery of phytoconstituents through nanodrug wagons approach
Kanoujia, J., & Parashar, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00018-x · Cited by 1
[Research progress of coarse-grained molecular dynamics in drug carrier materials].
Zhang, M., Gong, M., Wang, J., Chen, Z., & Zhou, L. (2023) · PubMed Central · doi:10.7507/1001-5515.202303008 · Cited by 1
Antioxidant in Oxidative Stress and Neurodegenerative Diseases
Zayyanu, T. (2023) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v11i8.02 · Cited by 1
“Nanosystems have the ability to change the pharmacokinetic characteristics of bioactive compounds, particularly those with low bioavailability rates, regardless of their structure and composition, tiny size, and high surface area, (2,7,8, 9&11) .”
Effect of Curcumin on the Process of Neuroinflammation Caused by COVID-19
Teixeira, S. A., Medeiros, S. R. A., Oliveira, G. L. D. S., Acha, B. T., & Pereira-Freire, J. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-7731-4_14 · Cited by 1
Neural regenerative nanomedicine: current therapies and future direction
Khatami, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820223-4.00009-7 · Cited by 1
Curcumin loaded drug delivery systems in the treatment of Alzheimer’s disease
Obulesu, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822448-9.00008-x · Cited by 1
Curcumin‐Based Food Packaging Material
Sánchez, L. T., Cañon‐Ibarra, A. F., Arboleda‐Murillo, J. A., & Villa, C. C. (2023) · doi:10.1002/9783527837304.ch8 · Cited by 1
Nanoparticles with Curcumin and Piperine Modulate Steroid Biosynthesis in Prostate CancerPreprint
Yakubu, J., Natsaridis, E., du Toit, T., Barata, I. S., Tagit, O., & Pandey, A. V. (2024) · Research Square · doi:10.21203/rs.3.rs-5326002/v1 · Cited by 1
Villalobos-Nova, K., Monroy-Moya, S., Maulen-Peñaloza, J., Pinto, G. C. M., & Cornejo, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220508175340
Kasirajan, M., Velmurugan, R., & Vijayalakshmi, A. (2022) · Journal of Experimental Biology and Agricultural Sciences · doi:10.18006/2022.10(4).812.817
A brief review of curcumin loaded nanoparticles
Sersemova, E. D., Tashkov, T., Miceva, D., Joveva, E., & Adzi-Andov, L. (2022) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2022.68.03.110
Nano Titania Applications in Cancer Theranostics
Qazi, R., Sajid, Z., Zhao, C., Rehman, F. U., & Mian, A. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.111626
Health Benefits in a New Era of Medicine: Probiotics as Nutraceutical
Gupta, D., Agrawal, N., Saxena, S., & Saxena, S. (2023) · SRMS Journal of Medical Science · doi:10.21761/jms.v7i02.05
guo, Y., Long, C., Ni, J., Zeng, J., Wang, J., Dai, Y., & Zhao, J. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4585847
Nanotechnology-based delivery system for phytochemicals in cancer therapy
Srivastava, A. K., Singh, D., & Singh, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15960-2.00008-8
Review on the Pharmacological Activities of Black Pepper
Anandh, D. R., & Priya, D. (2024) · Journal of Natural Remedies · doi:10.18311/jnr/2024/35022
liu, S., zhou, S., Wang, B., & Jia, Z. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4863410
Nanoparticles with Curcumin and Piperine Modulate Steroid Biosynthesis in Prostate CancerPreprint
Yakubu, J., Natsaridis, E., du Toit, T., Barata, I. S., Tagit, O., & Pandey, A. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.24.620019
Yousefi, S. A., Kazemzadeh, Y., Shirvani, H., & Shanjani, S. M. (2024) · Armaghane Danesh · doi:10.61186/armaghanj.29.5.657
Sahu, G., Satpathy, S., Vyas, K., radki, A., dewangan, M., Patel, V. J., Roy, A., & Ajazuddin, M. (2025) · Nanoscience & Nanotechnology-Asia · doi:10.2174/0122106812340671250108064331 · Cited by 2
Antifungal Activity of Some Extracts Supplemented with Silver Nanoparticles
Sultan, S. M., Yahya, R. T., Sultan, S. J., & Mohammed, A. A.-H. (2025) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_1339_23
Alzheimer's disease – An overview of nano herbal formulations
Patil, V. S., Patil, S., Patil, S. R., Pawar, A. S., & Shete, A. S. (2025) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2025.100042
Polymers as ligand and applications in drug delivery
Bindiya, Jain, P., Patel, P., & Jain, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33366-8.00001-4
Novel delivery systems for curcumin
Ahmed, M., & Basheer, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29196-8.00011-2
Nanotechnology and Secondary Metabolites
Kotha, K. K., Chandrakala, A. N., Kumarachari, R. K., Bukke, S. P. N., Sarangapani, P., & Karpagavalli, L. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1365-8.ch012
Li, S., Lin, Z., You, Y., Li, Y., Yu, W., & Lu, X. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150681
da Silva, A. B., Facchi, S. P., Machado, B. R., Teodoro, C. F., Gashti, M. P., Popat, K. C., Rubira, A. F., Bonafé, E. G., & Martins, A. F. (2026) · ACS Omega · doi:10.1021/acsomega.5c11646
Synaptic health in brain disorders: Impact of nanoplastic exposure
Ijomone, O. K., Omotosho, O. I., Awoyemi, I. L., Ovwere, I. R., Okeowo, O. M., Oyeniran, D. A., Oyerinde, T. O., Anadu, V. E., Gbayisomore, T. J., & Ijomone, O. M. (2026) · Advances in neurotoxicology · doi:10.1016/bs.ant.2026.03.011
Neuro-nutraceutical role of Indian spices, spice mixes and their bio-actives: An update
Vismaya, & Rajini, P. S. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106189
Enhancing curcumin solubility in water via solvent-antisolvent and sonication techniques
Handaratri, A., Fatimah, S., Kurniawansyah, F., & Sumarno (2026) · AIP conference proceedings · doi:10.1063/5.0330494
Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue
Jayalath, W. T., Gunaratna, M. J., Kadigamuwa, C. C., Thambiliyagodage, C. J., & Dahanayake, J. N. (2026) · Applied Biosciences · doi:10.3390/applbiosci5030069
“Antioxidants are compounds that can protect biomolecules from free radical-mediated oxidative damage, and most contain a phenolic group or a β -diketone group in their structure [41].”
Oxidative stress: mechanisms, implications and emerging therapeutic strategies
Namratha, B., Martis, G. J., Sushma, S., Hakkimane, S. S., & Gaonkar, S. L. (2026) · Advances in Redox Research · doi:10.1016/j.arres.2026.100191
Ahmed, S. S., Das, B., Muruganantham, P., Umashankar, M. S., & Madar, I. H. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05184-y
“…limit its ability to reach plasma levels comparable to the minimum inhibitory concentrations (MICs) observed against multidrug-resistant (MDR) bacterial pathogens, thereby limiting its efficacy in systemic infections (Rahman et al. 2020; Karkanis et al. 2011; Del Prado-Audelo et al. 2019).”
Murthy, M. K., & Samal, D. (2026) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-026-10323-9
“Au NPs (15–25 nm) at 5 mg/kg exhibited potent anti-inflammatory, neurotrophic, and antidepressant activities in several behavioral tests, such as FST, TST, and sucrose preference test (Del Prado-Audelo et al. 2019; Hu et al. 2026 ).”
Metadata
- Authors
- Del Prado-Audelo, M. L., Caballero-Florán, I. H., Meza-Toledo, J. A., Mendoza-Muñoz, N., González-Torres, M., Florán, B., Cortés, H., & Leyva-Gómez, G.
- Affiliations
- Laboratorio de Posgrado en Tecnología Farmacéutica, FES-Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Mexico
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (MX)
- Universidad del Valle de México (MX)
- Facultad de Ciencias Químicas, Universidad de Colima, C.P. Colima 28400, México
- CONACyT-Laboratorio de Biotecnología, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México 14389, Mexico
- Departamento de Fisiología, Biofísica & Neurociencias, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico
- Instituto Nacional de Rehabilitación (MX)
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Circuito Exterior S/N, Del. Coyoacán, C.P. Ciudad de México 04510, Mexico
- Corresponding author
- Cortés, Hernán
- ORCID
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2019-02-08
- Volume
- 9
- Issue
- 2
- Pages
- 56
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC6406762
- OpenAlex
- W2913877945
- Cited by
- 191
- References
- 129
- Citations by year
- 2026: 18 · 2025: 28 · 2024: 22 · 2023: 30 · 2022: 26 · 2021: 35 · 2020: 21 · 2019: 11
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México (PAPIIT TA 200318)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- curcumin, curcumin nanoparticles, brain disorders, nanoparticle drug delivery, bioavailability, water solubility, anti-inflammatory activity, antioxidant activity, polyphenols, neurodegenerative diseases
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Brain Diseases, Curcumin, Humans, Temperature, Molecular Structure, Curcuma, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review